This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AI x Next Generation Clinical Trials
April 22-23, 2026
Sheraton Boston HotelBoston, MA

Pujita Vaidya
Director, Regulatory Science and Policy at Sanofi
Speaker

Profile

Pujita Vaidya has 14+ years of experience in regulatory science and policy and is a leader in advancing patient-focused drug development (PFDD) throughout the medical product lifecycle. Pujita serves as a Regulatory Science and Policy Director at Sanofi, working to develop, advocate for, and implement Sanofi positions on regulatory policies partnering with cross-functional colleagues across Sanofi to advance strategic regulatory policy plans, as well as engaging with regulators and external stakeholders, in key areas such as digital/AI, PFDD, novel endpoints and biomarkers. She has also held positions at Novartis and Amgen. Previously, Pujita had a 7+ year tenure at FDA as the CDER's expert to advise FDA leadership, lead key initiatives including FDA’s Patient-focused Drug Development program, and provide strategic, regulatory, programmatic, and policy advice across FDA.

Agenda Sessions

  • Fireside Chat: Global Policy & Regulatory Update – Harmonizing Standards for AI-Enabled Trials

    10:15am
  • Designing Patient-Centric Trials: Rethinking Recruitment, Site Selection & the Future of Remote Research

    4:00pm